157 related articles for article (PubMed ID: 16476678)
1. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study.
Massin N; Cedrin-Durnerin I; Coussieu C; Galey-Fontaine J; Wolf JP; Hugues JN
Hum Reprod; 2006 May; 21(5):1204-11. PubMed ID: 16476678
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.
Balasch J; Fábregues F; Peñarrubia J; Carmona F; Casamitjana R; Creus M; Manau D; Casals G; Vanrell JA
Hum Reprod; 2006 Jul; 21(7):1884-93. PubMed ID: 16517559
[TBL] [Abstract][Full Text] [Related]
3. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
[TBL] [Abstract][Full Text] [Related]
4. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study.
Gleicher N; Barad DH
Hum Reprod; 2006 Nov; 21(11):3027; author reply 3027-8. PubMed ID: 17035548
[No Abstract] [Full Text] [Related]
6. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study.
Päkkilä M; Räsänen J; Heinonen S; Tinkanen H; Tuomivaara L; Mäkikallio K; Hippeläinen M; Tapanainen JS; Martikainen H
Hum Reprod; 2005 Aug; 20(8):2211-4. PubMed ID: 15817582
[TBL] [Abstract][Full Text] [Related]
7. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.
Bosdou JK; Venetis CA; Dafopoulos K; Zepiridis L; Chatzimeletiou K; Anifandis G; Mitsoli A; Makedos A; Messinis IE; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2016 May; 31(5):977-85. PubMed ID: 26956551
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
10. Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders--an observational pilot study.
Mitri F; Behan LA; Murphy CA; Hershko-Klement A; Casper RF; Bentov Y
Fertil Steril; 2016 Jan; 105(1):100-5.e1-6. PubMed ID: 26496380
[TBL] [Abstract][Full Text] [Related]
11. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
12. Poor responders in IVF: cancellation of a first cycle is not predictive of a subsequent failure.
Baka S; Makrakis E; Tzanakaki D; Konidaris S; Hassiakos D; Moustakarias T; Creatsas G
Ann N Y Acad Sci; 2006 Dec; 1092():418-25. PubMed ID: 17308168
[TBL] [Abstract][Full Text] [Related]
13. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.
González-Comadran M; Durán M; Solà I; Fábregues F; Carreras R; Checa MA
Reprod Biomed Online; 2012 Nov; 25(5):450-9. PubMed ID: 22999555
[TBL] [Abstract][Full Text] [Related]
14. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
[TBL] [Abstract][Full Text] [Related]
15. Performance of different ovarian reserve markers for predicting the numbers of oocytes retrieved and mature oocytes.
Lorusso F; Vicino M; Lamanna G; Trerotoli P; Serio G; Depalo R
Maturitas; 2007 Apr; 56(4):429-35. PubMed ID: 17184937
[TBL] [Abstract][Full Text] [Related]
16. Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization.
Meden-Vrtovec H; Mocnik-Roznik S; Tomazevic T; Virant-Klun I
J Reprod Med; 2003 Oct; 48(10):799-803. PubMed ID: 14619648
[TBL] [Abstract][Full Text] [Related]
17. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells.
Cai J; Lou HY; Dong MY; Lu XE; Zhu YM; Gao HJ; Huang HF
Fertil Steril; 2007 Jun; 87(6):1350-6. PubMed ID: 17296182
[TBL] [Abstract][Full Text] [Related]
18. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
[TBL] [Abstract][Full Text] [Related]
19. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders.
Kim CH; Howles CM; Lee HA
Fertil Steril; 2011 Feb; 95(2):679-83. PubMed ID: 20801436
[TBL] [Abstract][Full Text] [Related]
20. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
